Home > Insider Trading > Filing (0001104659-20-105778)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1182633	Md Melvin Sharoky	700 Us Highway 202/206 Bridgewater NJ 08807		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-09-14	100	$30.70	19,900	No	4	S	Indirect	Held by Baby Gator LLC
Common Stock	Disposition	2020-09-15	10,000	$30.33	9,900	No	4	S	Indirect	Held by Baby Gator LLC
Common Stock	Disposition	2020-09-15	9,900	$31.03	236,890	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Baby Gator LLC
No	4	S	Indirect	Held by Baby Gator LLC
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,714	Indirect	Held by The Sharoky Family Foundation, Inc.

Footnotes

This is the weighted average sales price representing 10,000 shares sold at prices ranging from $29.94 to $30.86 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
This is the weighted average sales price representing 9,900 shares sold at prices ranging from $30.89 to $31.14 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
The Reporting Person is a managing member of Baby Gator LLC.
The Reporting Person is Chairman of The Sharoky Family Foundation, Inc. and is one of three individuals who currently share voting and investment power over the shares held by The Sharoky Family Foundation, Inc. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.